| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARRAY BIOPHARMA INC | 12,765,862 | 114,127,000 | 7.41% | ||
| 2 | PENUMBRA INC COM | 1,034,408 | 86,321,000 | 5.60% | ||
| 3 | AMICUS THERAPEUTICS INC COM | 11,375,852 | 81,110,000 | 5.26% | ||
| 4 | PUMA BIOTECHNOLOGY | 1,725,414 | 64,185,000 | 4.17% | ||
| 5 | CLOVIS ONCOLOGY INC | 972,696 | 61,932,000 | 4.02% | ||
| 6 | Atara Biotherapeutics Inc | 2,734,118 | 56,186,000 | 3.65% | ||
| 7 | AGIOS PHARMACEUTICALS INC | 902,578 | 52,711,000 | 3.42% | ||
| 8 | MOLINA HEALTHCARE INC | 1,149,727 | 52,428,000 | 3.40% | ||
| 9 | PROTHENA CORP PLC | 849,483 | 47,393,000 | 3.08% | ||
| 10 | SEATTLE GENETICS INC | 696,386 | 43,775,000 | 2.84% | ||
| 11 | INCYTE CORP | 307,723 | 41,133,000 | 2.67% | ||
| 12 | GW PHARMACEUTICALS PLC | 332,544 | 40,218,000 | 2.61% | ||
| 13 | ALDER BIOPHARMACEUTICALS INC | 1,909,886 | 39,726,000 | 2.58% | ||
| 14 | XENCOR INC COM | 1,592,526 | 38,093,000 | 2.47% | ||
| 15 | WAVE LIFE SCIENCES LTD | 1,271,097 | 34,955,000 | 2.27% | ||
| 16 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 934,343 | 34,431,000 | 2.23% | ||
| 17 | Oxford Immunotec Global PLC | 2,004,849 | 31,055,000 | 2.02% | ||
| 18 | BOSTON SCIENTIFIC CORP | 1,200,099 | 29,846,000 | 1.94% | ||
| 19 | INC RESH HLDGS INC | 633,779 | 29,059,000 | 1.89% | ||
| 20 | ANTHEM INC | 175,328 | 28,996,000 | 1.88% | ||
| 21 | CHIMERIX INC | 4,325,055 | 27,594,000 | 1.79% | ||
| 22 | NEUROCRINE BIOSCIE COM USD0.001 | 622,345 | 26,948,000 | 1.75% | ||
| 23 | NEURODERM LTD | 924,304 | 24,540,000 | 1.59% | ||
| 24 | ICU MED INC | 160,543 | 24,515,000 | 1.59% | ||
| 25 | REGENXBIO INC COM | 1,269,131 | 24,494,000 | 1.59% | ||
| 26 | JOUNCE THERAPEUTICS INC | 1,114,160 | 22,523,000 | 1.46% | ||
| 27 | IMMUNOMEDICS INCORPORATED | 3,380,846 | 21,874,000 | 1.42% | ||
| 28 | PATHEON N V | 826,843 | 21,779,000 | 1.41% | ||
| 29 | DIPLOMAT PHARMACY INC COM | 1,254,342 | 20,007,000 | 1.30% | ||
| 30 | ENDOLOGIX INC | 2,717,394 | 19,674,000 | 1.28% | ||
| 31 | EXPRESS SCRIPTS HLDG CO | 293,807 | 19,365,000 | 1.26% | ||
| 32 | NANOSTRING TECHNOLOGIES INC | 934,424 | 18,567,000 | 1.21% | ||
| 33 | LA JOLLA PHARMACEUTICAL CO | 604,470 | 18,043,000 | 1.17% | ||
| 34 | CATALENT INC | 624,000 | 17,672,000 | 1.15% | ||
| 35 | CASCADIAN THERAPEUTICS INC | 4,072,424 | 16,860,000 | 1.09% | ||
| 36 | PAREXEL INTERNATIONAL CORPORATION | 260,231 | 16,423,000 | 1.07% | ||
| 37 | SPECTRANETICS CORP | 557,189 | 16,228,000 | 1.05% | ||
| 38 | BLUEPRINT MEDICINES CORP COM | 400,000 | 15,996,000 | 1.04% | ||
| 39 | IMMUNOGEN INC | 3,984,734 | 15,421,000 | 1.00% | ||
| 40 | SYROS PHARMACEUTICALS INC | 952,740 | 15,177,000 | 0.99% | ||
| 41 | EHEALTH INC COM | 1,191,334 | 14,344,000 | 0.93% | ||
| 42 | Audentes Therapeutics, Inc. | 820,836 | 13,987,000 | 0.91% | ||
| 43 | ARRAY BIOPHARMA INC 3 06/01/2020 | 9,000,000 | 12,763,000 | 0.83% | PRN | |
| 44 | CYTOMX THERAPEUTICS INC COM | 681,892 | 11,776,000 | 0.76% | ||
| 45 | MCKESSON CORP | 78,300 | 11,609,000 | 0.75% | ||
| 46 | CHARLES RIV LABS INTL INC | 121,307 | 10,912,000 | 0.71% | ||
| 47 | INVITAE CORP | 812,240 | 8,983,000 | 0.58% | ||
| 48 | MODEL N INCORPORATED | 822,314 | 8,593,000 | 0.56% | ||
| 49 | ProQR Therapeutics NV | 1,553,225 | 7,766,000 | 0.50% | ||
| 50 | FATE THERAPEUTICS INC | 1,419,058 | 6,457,000 | 0.42% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-17-000012, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
